ArticleBMC infectious diseases2025
The shifting burden of mortality among men with HIV in Japan between 2007 and 2024: a single-center retrospective cohort study.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAntiretroviral therapy (ART) has transformed HIV infection from a fatal disease into a chronic condition and improved the life expectancy of people living with HIV (PLWH). Few studies have examined long-term changes in standardized mortality ratios (SMRs) by age and cause of death among PLWH in Japan. This study investigated the changes in SMR among men with HIV infection in Japan over an 18-year period, focusing on age at death and the contribution of malignancies.
methodsWe conducted a retrospective cohort study of men with HIV infection who received care at Osaka National Hospital between 2007 and 2024. Data were extracted from medical records. Causes of death were classified according to the Coding Causes of Death in HIV protocol. SMRs were calculated based on the general male population of Japan.
resultsA total of 3,793 patients were included with 35,007 person-years of follow-up. The median age on enrollment was 36.3 years, and the median follow-up period was 10.1 years. Of the patients, 230 died during the study period, with a median age at death of 53.4 years. The causes of death included 44 deaths from AIDS-defining illnesses, 20 deaths from AIDS-defining malignancies, 51 deaths from non-AIDS-defining malignancies; and 57 deaths of unknown cause. The SMR decreased from 4.11 in 2007–2011 to 1.27 in 2021–2024, with different patterns in different age groups. In recent years, the SMR in younger and older age groups approached that of the general population, but remained high in the 40–64-years age group, and in patients with CD4 counts < 200 cells/μL or viral loads ≥1000 copies/mL within the calendar year. The SMR for malignancies also remained high in the 40–64-years age group (2.28 in 2021–2024).
conclusionsAmong men with HIV infection in Japan, the risk of death has declined markedly with the widespread use of ART, approaching that of the general population, particularly in younger and older age groups. However, elevated mortality due to non-AIDS-related causes, particularly malignancies, persists among middle-aged men. Future HIV care should prioritize viral suppression and enhancing age-appropriate cancer screening.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.